Cognitive behavioral therapy for psychosis
(CBTp)
- Therapy · Cognitive-behavioral
- Mixed or contested
- Published October 19, 2026
- 15 sources
- 5 min read
In short
Related in this topic
On this page
Key facts
- Tradition
- Cognitive-behavioral
- Developed by
- British clinical research groups, including D. G. Kingdon and D. Turkington; P. Chadwick and M. Birchwood; and E. Kuipers, P. Garety and colleagues
- Origin
- 1990s, United Kingdom
- Typical format
- Individual sessions; NICE describes at least 16 planned one-to-one sessions following a treatment manual
- Most researched for
- Schizophrenia and related psychotic disorders (positive symptoms); Distressing voices and delusional beliefs
- Also known as
- CBT for psychosis; Cognitive behavioural therapy for psychosis; CBT for schizophrenia
State of the evidence
Mixed or contestedMeta-analyses find small effects on positive symptoms, on the order of 0.25 to 0.4 standard deviations[1][2][3]. The size shrinks in trials with masked assessors, to a non-significant 0.08 for positive symptoms in one analysis[2], while a network meta-analysis found the effect robust to blinding and researcher allegiance[3]. A Cochrane review found no clear advantage over other psychosocial therapies, with mostly low-quality evidence[4].
Evidence labels summarise the research literature; they are not recommendations. How labels are assigned
Cognitive behavioral therapy for psychosis (CBTp) is an individual psychological therapy that helps people with psychosis re-evaluate their appraisals of their experiences, appraisals that can affect their level of distress and problematic behavior[4]. It adapts the methods of cognitive behavioral therapy to positive symptoms such as distressing voices and delusional beliefs, and it is usually offered alongside standard care rather than in place of it[5][4].
The therapy is built on an individual case formulation[6] . It links a person’s thoughts, feelings or actions to their symptoms and works on the perceptions, beliefs and reasoning that relate to the symptoms being targeted[7]. The evidence for it is disputed.
Origins in British clinical research
The idea that delusions can be addressed in psychotherapy predates the modern therapy: Aaron T. Beck published a case report in 1952 of the successful outpatient psychotherapy of a patient with a long-standing delusion[8]. The approach took its current form in the UK in the 1990s. In Nottinghamshire, Kingdon and Turkington treated 64 consecutively referred patients with schizophrenia with cognitive behavioral psychotherapy as an addition to standard treatment, supplemented by a destigmatizing, “normalizing” rationale for how symptoms emerge, and reported the techniques safe and acceptable to patients and relatives[9].
Two lines of work defined the targets. Chadwick and Birchwood argued that people’s responses to persistent voices reflect their beliefs about the voices rather than the voices’ content: voices believed to be malevolent provoked fear and resistance, those believed benevolent were courted, and in 31% of cases the beliefs were incongruous with what the voices said. In four patients, systematically disputing and testing beliefs about the voices’ power, identity and purpose reduced conviction and distress[10]. Garety, Kuipers and colleagues set out a cognitive model of how positive symptoms are formed and maintained that also incorporated social factors[11].
The first large randomized trial came from the London–East Anglia group in 1997. Sixty participants with at least one distressing positive symptom that had not responded to standard treatment were allocated to nine months of individualized CBT plus standard care or to standard care alone. Only the CBT group improved significantly, with a 25% reduction in overall symptom ratings; 50% were treatment responders against 31% of controls, and satisfaction with therapy was high[5]. A 2014 debate in the BMJ describes it as a pioneering trial that more than 50 others have followed[12].
Formulation of distressing beliefs and voices
The therapy works from an individual formulation. A meta-analysis that selected trials of individually tailored, case-formulation CBT aimed at hallucinations and delusions describes this as the defining feature of the approach[6]. The NICE schizophrenia guideline sets out what such therapy should include: a treatment manual that helps people establish links between their thoughts, feelings or actions and their current or past symptoms or functioning, and re-evaluation of perceptions, beliefs or reasoning related to the target symptoms. It should also include at least one of the following: self-monitoring of thoughts, feelings or behaviors in relation to symptoms, alternative ways of coping, reduction of distress, or improvement of functioning[7].
With voices, the work concerns the person’s beliefs about the voice, such as its power, identity and purpose, which in Chadwick and Birchwood’s account shape the distress the voice causes[10]. With delusional beliefs, the work centers on re-evaluating the perceptions, beliefs and reasoning involved[7], and in Kingdon and Turkington’s version it is supplemented by a destigmatizing rationale for how symptoms emerge[9].
A secondary analysis of one trial examined which elements matter. Consistent delivery of the full therapy, including specific cognitive and behavioral techniques, was associated with more months in remission and fewer psychotic and affective symptoms, whereas partial therapy limited to engagement and assessment was not effective[13].
Status in the NICE guideline
The National Institute for Health and Care Excellence recommends that CBT be offered to all people with psychosis or schizophrenia, starting either during the acute phase or later, including in inpatient settings[7]. The guideline also lists individual CBT among the psychological interventions for first-episode psychosis, for people with persisting positive and negative symptoms and for people in remission, and for people considered at increased risk of developing psychosis[7][7][7]. It specifies delivery on a one-to-one basis over at least 16 planned sessions[7].
Meta-analyses and the role of masking
The size of the effect has been disputed since the late 2000s. A 2008 meta-analysis of 34 trials led by Wykes found a benefit on the targeted symptom (effect size 0.40) and significant effects of 0.35 to 0.44 on positive and negative symptoms, functioning, mood and social anxiety, but no effect on hopelessness. Trials whose raters knew the group allocation had effect sizes inflated by about 50% to 100%. Among methodologically rigorous trials the estimated effect was 0.22, with a confidence interval whose lower end approached zero, and effects on secondary outcomes such as negative symptoms were no longer significant[1].
Jauhar and colleagues reached a more skeptical reading in 2014. Pooled effect sizes were 0.33 for overall symptoms in 34 studies, 0.25 for positive symptoms and 0.13 for negative symptoms. Masking of outcome assessment significantly moderated the results: in masked studies the effect fell to 0.15 for overall symptoms and to a non-significant 0.08 for positive symptoms. The type of control intervention did not moderate the effect, and there was no consistent evidence of publication bias. The authors concluded that the effect is small and shrinks further when sources of bias are controlled[2]. A later meta-analysis with overlapping authors found a small effect on functioning at the end of treatment that was not evident at follow-up, a small effect on distress that became non-significant after adjustment for possible publication bias, and no effect on quality of life[14].
The debate over overselling
The two readings were set against each other in the 2014 BMJ debate. McKenna argued that only two of about nine moderately sized or large blind trials had positive results on their primary outcomes, that the meta-analyses behind the 2009 NICE guideline ran many non-independent comparisons and were vulnerable to chance findings, and that the therapy had been oversold[12]. Kingdon replied that meta-analyses consistently found effects of around 0.3, that in nearly all the trials in his opponents’ own forest plots CBTp was favored over controls, and that excluding studies as unmasked was in several cases disputable, since authors of studies described as unclear had confirmed that assessors were masked. He argued that trials of very brief therapy or of populations such as people with coexisting substance misuse had diluted the pooled estimates. Kingdon declared royalties and research grants for developing the therapy[12].
Later syntheses have not ended the dispute. A meta-analysis of 48 trials comparing psychological interventions found CBT more efficacious than other interventions pooled for positive symptoms (g = 0.16), a result robust to risk of bias but not significant in a low-powered sensitivity analysis for researcher allegiance[15]. A meta-analysis of formulation-based CBT found effect sizes of 0.36 for delusions and 0.44 for hallucinations; the delusion effect lost significance against active treatments and fell to 0.24 in blinded studies, while the hallucination effect held[6]. A 2018 network meta-analysis of 53 trials with 4,068 participants found that CBT reduced positive symptoms more than inactive control, treatment as usual and supportive therapy, with standardized mean differences of 0.29 to 0.47, results consistent in sensitivity analyses for allegiance and assessor blinding, though confidence in the estimates ranged from moderate to very low[3]. A Cochrane review of 36 trials found no clear and convincing advantage for CBT over other, sometimes less sophisticated and less expensive, psychosocial therapies, with evidence mostly of low or very low quality[4].
Sources15
Numbered in order of first citation.
- 1.Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2008). Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin, 34(3), 523–537. https://doi.org/10.1093/schbul/sbm114
- 2.Jauhar, S., McKenna, P. J., Radua, J., Fung, E., Salvador, R., & Laws, K. R. (2014). Cognitive–behavioural therapy for the symptoms of schizophrenia: Systematic review and meta-analysis with examination of potential bias. British Journal of Psychiatry, 204(1), 20–29. https://doi.org/10.1192/bjp.bp.112.116285
- 3.Bighelli, I., Salanti, G., Huhn, M., Schneider-Thoma, J., Krause, M., Reitmeir, C., Wallis, S., Schwermann, F., Pitschel-Walz, G., Barbui, C., Furukawa, T. A., & Leucht, S. (2018). Psychological interventions to reduce positive symptoms in schizophrenia: Systematic review and network meta‐analysis. World Psychiatry, 17(3), 316–329. https://doi.org/10.1002/wps.20577
- 4.Jones, C., Hacker, D., Meaden, A., Cormac, I., Irving, C. B., Xia, J., Zhao, S., Shi, C., & Chen, J. (2018). Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database of Systematic Reviews, 2018(11), CD008712. https://doi.org/10.1002/14651858.CD008712.pub3
- 5.Kuipers, E., Garety, P., Fowler, D., Dunn, G., Bebbington, P., Freeman, D., & Hadley, C. (1997). London–East Anglia randomised controlled trial of cognitive–behavioural therapy for psychosis. I: Effects of the treatment phase. British Journal of Psychiatry, 171(4), 319–327. https://doi.org/10.1192/bjp.171.4.319
- 6.van der Gaag, M., Valmaggia, L. R., & Smit, F. (2014). The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: A meta-analysis. Schizophrenia Research, 156(1), 30–37. https://doi.org/10.1016/j.schres.2014.03.016
- 7.National Institute for Health and Care Excellence (2014). Psychosis and schizophrenia in adults: Prevention and management (NICE clinical guideline CG178). National Institute for Health and Care Excellence. www.nice.org.uk/guidance/cg178
- 8.Beck, A. T. (1952). Successful outpatient psychotherapy of a chronic schizophrenic with a delusion based on borrowed guilt. Psychiatry, 15(3), 305–312. https://doi.org/10.1080/00332747.1952.11022883
- 9.Kingdon, D. G., & Turkington, D. (1991). The use of cognitive behavior therapy with a normalizing rationale in schizophrenia. Preliminary report. The Journal of Nervous and Mental Disease, 179(4), 207–211. https://doi.org/10.1097/00005053-199104000-00005
- 10.Chadwick, P., & Birchwood, M. (1994). The omnipotence of voices: A cognitive approach to auditory hallucinations. British Journal of Psychiatry, 164(2), 190–201. https://doi.org/10.1192/bjp.164.2.190
- 11.Garety, P. A., Kuipers, E., Fowler, D., Freeman, D., & Bebbington, P. E. (2001). A cognitive model of the positive symptoms of psychosis. Psychological Medicine, 31(2), 189–195. https://doi.org/10.1017/S0033291701003312
- 12.McKenna, P., & Kingdon, D. (2014). Has cognitive behavioural therapy for psychosis been oversold?. BMJ, 348(mar25 2), g2295. https://doi.org/10.1136/bmj.g2295
- 13.Dunn, G., Fowler, D., Rollinson, R., Freeman, D., Kuipers, E., Smith, B., Steel, C., Onwumere, J., Jolley, S., Garety, P., & Bebbington, P. (2012). Effective elements of cognitive behaviour therapy for psychosis: Results of a novel type of subgroup analysis based on principal stratification. Psychological Medicine, 42(5), 1057–1068. https://doi.org/10.1017/S0033291711001954
- 14.Laws, K. R., Darlington, N., Kondel, T. K., McKenna, P. J., & Jauhar, S. (2018). Cognitive behavioural therapy for schizophrenia - outcomes for functioning, distress and quality of life: A meta-analysis. BMC Psychology, 6(1), 32. https://doi.org/10.1186/s40359-018-0243-2
- 15.Turner, D. T., van der Gaag, M., Karyotaki, E., & Cuijpers, P. (2014). Psychological interventions for psychosis: A meta-analysis of comparative outcome studies. American Journal of Psychiatry, 171(5), 523–538. https://doi.org/10.1176/appi.ajp.2013.13081159
Further reading
- McKenna, P., & Kingdon, D. (2014). Has cognitive behavioural therapy for psychosis been oversold?. BMJ, 348(mar25 2), g2295. https://doi.org/10.1136/bmj.g2295
- Bighelli, I., Salanti, G., Huhn, M., Schneider-Thoma, J., Krause, M., Reitmeir, C., Wallis, S., Schwermann, F., Pitschel-Walz, G., Barbui, C., Furukawa, T. A., & Leucht, S. (2018). Psychological interventions to reduce positive symptoms in schizophrenia: Systematic review and network meta‐analysis. World Psychiatry, 17(3), 316–329. https://doi.org/10.1002/wps.20577
Related entries 6
Cite this entry
APA 7
Psych Dictionary. (2026, October 19). Cognitive behavioral therapy for psychosis (CBTp). In Psych Dictionary. https://www.psychdictionary.com/therapies/cbt-for-psychosis
MLA 9
“Cognitive Behavioral Therapy for Psychosis (CBTp).” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/therapies/cbt-for-psychosis.